Revisiones y ensayos clínicos sobre Salmonella enteritidis

Respuesta generada por Itaca · 42 fuentes · 9 de septiembre de 2026

Pregunta original

De la bacteria salmonela enteriditis dame 3 revisiones sistematicas que traiga prisma, diagrama de bosque, que traiga el metodo de investigacion, las bases de datos, criterios de eligibilidad, como se selecciono a muestra, principios eticos, analisis estaditiscos. Tambien dame del tema 3 revisiones narrativas y 3 ensayos clinicos

Summary

The literature on Salmonella enterica serovar Enteritidis (S. Enteritidis) contains many reviews, but relatively few systematic reviews restricted exclusively to this serovar. The most appropriate evidence includes reviews of S. Enteritidis epidemiology, egg contamination, poultry production, antimicrobial resistance, and invasive nontyphoidal salmonellosis. Three relevant systematic reviews are listed below; their exact scope is identified so that reviews of broader Salmonella populations are not incorrectly presented as S. Enteritidis-only studies. Human clinical trials specifically involving S. Enteritidis have mainly evaluated multivalent vaccines containing S. Enteritidis plus other serovars.

1. Systematic reviews with PRISMA and meta-analysis

Systematic review 1: Global distribution of invasive nontyphoidal *Salmonella

Reference:
Prevalence and distribution of non-typhoidal Salmonella enterica serovars isolated from normally sterile sites: a systematic review and meta-analysis. Epidemiology and Infection. 2023;152:e4.
PubMed link [1]

Research topic and population

This review evaluated Salmonella isolates recovered from normally sterile sites, particularly blood and cerebrospinal fluid, with emphasis on invasive nontyphoidal salmonellosis. S. Enteritidis was analyzed as a specific serovar within the pooled data.

Among serotyped isolates, the pooled prevalence of S. Enteritidis was reported as approximately 37.8%, although this estimate reflects the included invasive-disease studies and should not be interpreted as the prevalence of all S. Enteritidis infections globally.

Method of investigation

  • Systematic review and meta-analysis.
  • Structured literature search.
  • Study selection according to systematic-review methodology.
  • Reporting based on PRISMA principles.
  • Extraction of data on serogroup, serovar, geographical region, specimen type, and invasive disease.

Databases

The review searched major biomedical and multidisciplinary databases. The PubMed record should be consulted for the complete search strategy and database list because database coverage may vary according to the individual search stage.

Eligibility criteria

Studies were eligible when they:

  • Reported nontyphoidal Salmonella isolates from normally sterile sites.
  • Provided serogroup or serovar information.
  • Included human invasive disease data.
  • Reported sufficient information to calculate proportions.

Studies without adequate serovar information or without relevant invasive-disease specimens were excluded.

Sample selection

The authors screened identified records, removed duplicates, evaluated titles and abstracts, and assessed potentially eligible full-text articles. The final sample consisted of studies reporting invasive nontyphoidal Salmonella isolates. The review included 82 studies and more than 24,000 serogrouped isolates.

Ethical principles

Because this was a secondary analysis of previously published studies, direct recruitment of human participants did not occur. Individual informed consent and new institutional review-board approval were therefore generally not applicable to the review itself. Ethical approval would have been the responsibility of the original studies.

Statistical analysis

The analysis included:

  • Pooled proportions.
  • 95% confidence intervals.
  • Random-effects meta-analysis.
  • Subgroup analyses by serogroup and serovar.
  • Heterogeneity assessment.
  • Forest plots for pooled estimates.

PRISMA diagram and forest plot

The publication includes a study-selection flow diagram and graphical presentation of pooled estimates. S. Enteritidis was included as a serovar-specific subgroup.

Main value and limitation

This is one of the strongest systematic sources for the role of S. Enteritidis in invasive nontyphoidal salmonellosis. However, it is not restricted exclusively to S. Enteritidis, and the results cannot be directly extrapolated to food contamination, poultry prevalence, or uncomplicated gastroenteritis.


Systematic review 2: Age and timing of challenge in poultry studies

Reference:
Age of challenge is important in Salmonella Enteritidis studies in pullets and hens: a systematic review. 2024/2025 publication.
PubMed link [2]

Research topic and population

This review focused specifically on experimental S. Enteritidis infection in pullets and laying hens. The main question concerned whether the age at which birds were challenged influenced colonization, shedding, organ invasion, and egg contamination.

Method of investigation

  • Systematic review of experimental animal studies.
  • Studies were compared according to bird age, challenge protocol, inoculum, route of exposure, and outcome assessment.
  • The review used PRISMA-style study identification and selection procedures.

Databases

The complete publication should be consulted for the exact search strings and final list of databases. The search used biomedical and agricultural literature sources relevant to poultry and veterinary microbiology.

Eligibility criteria

Eligible studies generally:

  • Used pullets or laying hens.
  • Experimentally challenged animals with S. Enteritidis.
  • Reported the age at challenge.
  • Reported at least one microbiological outcome, such as fecal shedding, cecal colonization, tissue recovery, or egg contamination.
  • Provided sufficient experimental information for comparison.

Studies were excluded when the serovar was not identified as S. Enteritidis, when the challenge age was unavailable, or when outcomes were insufficiently reported.

Sample selection

The sample consisted of experimental poultry studies rather than human participants. Records were screened by title and abstract, followed by full-text assessment. The final included studies were grouped according to bird age and experimental outcome.

Ethical principles

No new animals were enrolled by the review authors. Ethical approval therefore depended on the original animal experiments. A systematic review of animal studies should report whether the original studies documented animal-welfare approval, humane endpoints, housing standards, and adherence to national animal-research regulations.

Statistical analysis

The review primarily compared outcomes across experimental conditions. Depending on the outcome and available data, analyses included:

  • Descriptive synthesis.
  • Comparison of effect direction across age groups.
  • Quantitative synthesis where study data were sufficiently comparable.
  • Forest plots when pooled estimates were statistically appropriate.

PRISMA diagram and forest plot

The publication should be checked directly for the exact PRISMA flow diagram and the individual forest plots. This review is particularly useful when the research question concerns poultry control, vaccine testing, feed interventions, or egg contamination.

Main value and limitation

This is a S. Enteritidis-specific systematic review, but it concerns experimental poultry studies rather than human clinical disease. Its findings should not be presented as evidence of treatment efficacy in humans.


Systematic review 3: Antimicrobial resistance in *Salmonella

  • in South Africa

Reference:
Prevalence of Antibiotic Resistance in Salmonella Serotypes Concurrently Isolated from the Environment, Animals, and Humans in South Africa: A Systematic Review and Meta-Analysis. Antibiotics. 2021;10:1071.
PMC full text [3]

Research topic and population

This review evaluated antimicrobial resistance among Salmonella isolates obtained from:

  • Humans.
  • Poultry and other animals.
  • Environmental sources.

The review included multiple serovars, including S. Enteritidis, but it did not provide a separate pooled meta-analysis restricted to S. Enteritidis.

Method of investigation

  • Systematic review and meta-analysis.
  • Conducted according to PRISMA 2020 principles.
  • Data extracted independently from eligible publications.
  • Study characteristics entered into structured data forms and spreadsheets.

Databases

The authors searched:

  • PubMed.
  • ScienceDirect.
  • African Journals Online.
  • Scopus.

The last search was performed in June 2021.

Eligibility criteria

Studies were included when they:

  • Were performed in South Africa.
  • Reported quantitative Salmonella prevalence or antimicrobial-resistance data.
  • Described sample type and diagnostic method.
  • Reported sample numbers and positive isolates.
  • Were published in English.
  • Were published within the prespecified period.

Studies were excluded when they were:

  • Reviews, books, or book chapters.
  • Case reports.
  • Abstracts without full text.
  • Missing total sample numbers.
  • Outside South Africa.
  • Insufficiently detailed for quantitative extraction.

Sample selection

The review identified 2,527 records. After screening and duplicate removal:

  • 38 full-text articles were assessed.
  • 18 were excluded.
  • 20 articles were included.
  • The review included approximately 2,930 isolates for the principal review analysis.

The authors extracted the publication year, region, sample type, target population, laboratory method, number of isolates, antimicrobial susceptibility results, and multidrug-resistance data.

Ethical principles

The review did not recruit participants or collect new biological samples. The article reports no new institutional ethics approval or informed-consent process. Ethical approval would therefore pertain to the primary studies.

Statistical analysis

The authors reported:

  • Pooled prevalence estimates.
  • 95% confidence intervals.
  • Cochran’s Q test.
  • I² heterogeneity statistics.
  • Forest plots.
  • Funnel plots.
  • Begg’s test.
  • Egger’s test.
  • Comprehensive Meta-Analysis software.

A random-effects approach was used for pooled estimates. Considerable heterogeneity was present in several analyses, limiting direct comparison between regions, populations, and sample types.

PRISMA diagram and forest plots

The article contains:

  • A PRISMA flow diagram.
  • Forest plots for pooled estimates.
  • Supplementary forest plots for overall Salmonella prevalence.
  • Forest plots for selected antimicrobial-resistance outcomes.

Main value and limitation

This review is useful for antimicrobial-resistance methodology and One Health surveillance. However, because its principal analysis combines multiple Salmonella serovars and sources, it should not be cited as a precise estimate of S. Enteritidis resistance unless the individual study data are extracted separately.

Important methodological caution

There is a major difference between:

  1. A systematic review that includes S. Enteritidis as one subgroup; and
  2. A systematic review restricted exclusively to S. Enteritidis.

The first and third reviews above are broader than S. Enteritidis. The poultry review is more serovar-specific. For an academic assignment, the exact title, population, serovar, outcomes, and denominator should be stated clearly to avoid overstating the evidence.

2. Three narrative reviews

Narrative review 1: Egg contamination

Reference:
Humphrey TJ. Contamination of egg shell and contents with Salmonella enteritidis: a review. International Journal of Food Microbiology. 1994;21:31–40.
PubMed link [4]

Main content

This review discusses:

  • Routes by which eggs become contaminated.
  • Internal versus external egg contamination.
  • Colonization of the reproductive tract.
  • Environmental contamination of shells.
  • Effects of egg handling, storage, and cooking.
  • Public-health implications.

It is a classical narrative review and does not constitute a PRISMA systematic review.


Narrative review 2: The chicken–egg transmission cycle

Reference:
De Buck J, et al. The chicken, the egg and Salmonella enteritidis. Environmental Microbiology. 2001;3:421–430.
PubMed link [5]

Main content

The review examines:

  • Adaptation of S. Enteritidis to poultry and egg-associated environments.
  • Bacterial growth patterns.
  • Cell-surface characteristics.
  • Transmission between hens, eggs, and the food chain.
  • The biological basis for persistence in poultry production.

The article synthesizes microbiological and epidemiological evidence but is not a quantitative systematic review.


Narrative review 3: Mechanisms of egg contamination

Reference:
Gantozis N, et al. Mechanisms of egg contamination by Salmonella Enteritidis. FEMS Microbiology Reviews. 2009;33:718–738.
PubMed link [6]

Main content

This review focuses on:

  • Colonization of the chicken reproductive tract.
  • Vertical and pseudo-vertical transmission.
  • Contamination of egg contents before shell formation.
  • Bacterial interaction with ovarian and oviduct tissues.
  • Virulence factors and host adaptation.
  • Implications for vaccination, biosecurity, and poultry management.

The conclusions are mechanistic and biological; they should not be treated as equivalent to clinical-outcome evidence.

3. Three clinical trials involving vaccines containing *S. Enteritidis

Direct clinical trials of antibiotic treatment specifically restricted to S. Enteritidis are uncommon. The most relevant human trials have evaluated vaccines against invasive nontyphoidal Salmonella, including an S. Enteritidis component.

Clinical trial 1: iNTS-GMMA vaccine, first-in-human study

Reference:
Safety and immunogenicity of the invasive non-typhoidal Salmonella iNTS-GMMA vaccine: a first-in-human, randomised, dose-escalation trial. EBioMedicine. 2025;119:105903.
PubMed link [7]

Design

  • Phase 1.
  • Randomized.
  • Placebo-controlled.
  • Dose-escalation.
  • Single-center.
  • Healthy adults aged 18–55 years.
  • Vaccine containing GMMA antigens from S. Enteritidis and S. Typhimurium.

Outcomes

  • Safety.
  • Reactogenicity.
  • Antibody responses.
  • Immunogenicity against O-antigen targets.

Interpretation

This trial supports early-phase safety and immunogenicity assessment. It does not establish clinical protection against naturally acquired S. Enteritidis infection.


Clinical trial 2: SALVO trial in Oxford

Trial: Salmonella Vaccine Study in Oxford, SALVO.
Registration: ISRCTN51750695; EudraCT 2020-000510-14.
Oxford Vaccine Group publication page [8]
UK Health Research Authority summary [9]

Design

  • Phase 1.
  • Randomized.
  • Placebo-controlled.
  • Participant- and observer-blinded.
  • Healthy adults aged 18–55 years.
  • Three intramuscular injections at 0, 2, and 6 months.
  • Bivalent vaccine containing S. Enteritidis and S. Typhimurium GMMA.

Outcomes

  • Primary: safety and tolerability.
  • Secondary: antibody response and immunogenicity.
  • Exploratory: broader immune responses.

Ethical principles

The trial received approval from the South Central–Oxford A Research Ethics Committee. Participants were healthy volunteers and therefore required informed consent, safety monitoring, and prespecified stopping or review procedures.

Interpretation

The study is relevant to prevention of invasive nontyphoidal salmonellosis but was not designed to measure prevention of ordinary foodborne gastroenteritis caused specifically by S. Enteritidis.


Clinical trial 3: Trivalent Salmonella conjugate vaccine

Trial: Phase 1 randomized, placebo-controlled, dose-escalation study of a trivalent Salmonella vaccine containing S. Enteritidis, S. Typhimurium, and S. Typhi Vi conjugate antigen.
ClinicalTrials.gov identifier: NCT03981952.
ClinicalTrials.gov link [10]
PubMed publication [11]

Design

  • Phase 1.
  • Randomized.
  • Placebo-controlled.
  • Dose-escalation.
  • Healthy adults.
  • Trivalent vaccine containing antigens targeting S. Enteritidis, S. Typhimurium, and typhoid S. Typhi.

Outcomes

  • Safety.
  • Reactogenicity.
  • Serum antibody responses.
  • Immunogenicity against vaccine antigens.

Interpretation

This is an early-phase vaccine trial. Its findings concern safety and immune response, not efficacy against naturally occurring S. Enteritidis disease. Direct comparison with the iNTS-GMMA vaccine is not justified because the products, antigens, schedules, populations, and immunologic assays differ.

Suggested way to present the evidence in an academic paper

A defensible conclusion would be:

Evidence concerning Salmonella Enteritidis is heterogeneous. Serovar-specific systematic reviews are available mainly in poultry and invasive-disease research, whereas antimicrobial-resistance and surveillance reviews commonly combine S. Enteritidis with other Salmonella serovars. Human clinical trials have focused primarily on candidate multivalent vaccines and have so far provided early-phase safety and immunogenicity evidence rather than definitive evidence of clinical protection.

Fuentes

  1. https://pubmed.ncbi.nlm.nih.gov/37850326/
  2. https://pubmed.ncbi.nlm.nih.gov/39392015/
  3. https://pmc.ncbi.nlm.nih.gov/articles/PMC8698067/
  4. https://pubmed.ncbi.nlm.nih.gov/8155476/
  5. https://pubmed.ncbi.nlm.nih.gov/11553232/
  6. https://pubmed.ncbi.nlm.nih.gov/19207743/
  7. https://pubmed.ncbi.nlm.nih.gov/40907249/
  8. https://www.ovg.ox.ac.uk/publications/1569563
  9. https://www.hra.nhs.uk/planning-and-improving-research/application-summaries/research-summaries/salmonella-vaccine-study-in-oxford-salvo/
  10. https://clinicaltrials.gov/study/NCT03981952
  11. https://pubmed.ncbi.nlm.nih.gov/41001453/
  12. https://pmc.ncbi.nlm.nih.gov/articles/PMC12455111/
  13. https://www.medrxiv.org/content/10.1101/2023.06.13.23291315v1.full.pdf
  14. https://www.ivi.int/our-impact/journal-publications/?id=15779
  15. https://www.coalitionagainsttyphoid.org/wp-content/uploads/2024/01/4.Peter-Skidmore-CaT-SALVO-Presentation_FINAL_APPROVED.pdf
  16. https://gala.gre.ac.uk/id/eprint/50761/1/50761%20GRACE_Systematic_Review_And_Meta-Analysis_On_Prevalence_And_Antimicrobial_Resistance_Patterns_(OA)_2025.pdf
  17. https://www.canadianveterinarians.net/media/zehatbcj/cvj-2025-0143-supplmat_figs1-s2-tabs1-s2.pdf
  18. https://cdn.clinicaltrials.gov/large-docs/52/NCT03981952/Prot_SAP_000.pdf
  19. https://pmc.ncbi.nlm.nih.gov/articles/PMC10789991/
  20. https://pmc.ncbi.nlm.nih.gov/articles/PMC13270084/
  21. https://repository.up.ac.za/server/api/core/bitstreams/7cc136ec-5f46-4e56-bdd0-903447901b95/content
  22. https://www.frontiersin.org/journals/microbiology/articles/10.3389/fmicb.2022.802625/full
  23. https://colab.ws/articles/10.1186%2Fs41182-025-00731-7
  24. https://pubmed.ncbi.nlm.nih.gov/15845226/
  25. https://pubmed.ncbi.nlm.nih.gov/23300320/
  26. https://pubmed.ncbi.nlm.nih.gov/31190705/
  27. https://pubmed.ncbi.nlm.nih.gov/7611983/
  28. https://pubmed.ncbi.nlm.nih.gov/21637719/
  29. https://pubmed.ncbi.nlm.nih.gov/24960614/
  30. https://pubmed.ncbi.nlm.nih.gov/35148491/
  31. https://pubmed.ncbi.nlm.nih.gov/24102082/
  32. https://pubmed.ncbi.nlm.nih.gov/36507074/
  33. https://pubmed.ncbi.nlm.nih.gov/7908823/
  34. https://clinicaltrials.gov/study/NCT06213506
  35. https://delta.larvol.com/Products/?ProductId=f84f2839-e8d1-42bd-9249-88c3eeddbda4
  36. https://atlasbyauro.com/trials/study/a-study-on-the-safety-reactogenicity-and-immune-response-to-nct06213506
  37. https://pmc.ncbi.nlm.nih.gov/articles/PMC12890034/
  38. https://www.tandfonline.com/doi/full/10.1080/14760584.2023.2270596
  39. https://cdn.clinicaltrials.gov/large-docs/00/NCT05480800/Prot_000.pdf
  40. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1821495/full
  41. https://www.medschool.umaryland.edu/news/2025/new-vaccine-shows-promise-against-typhoid-and-invasive-salmonella-in-first-human-trial.html
  42. https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/nontyphoidal-salmonella-disease

Respuesta generada por inteligencia artificial a partir de las fuentes citadas. Verifica las fuentes antes de aplicarla.

¿Tienes una pregunta sobre tu propio caso? Itaca responde con fuentes en segundos.

Hacer una pregunta

Más preguntas sobre salmonelosis